GB201811431D0 - Cancer treatment - Google Patents

Cancer treatment

Info

Publication number
GB201811431D0
GB201811431D0 GBGB1811431.4A GB201811431A GB201811431D0 GB 201811431 D0 GB201811431 D0 GB 201811431D0 GB 201811431 A GB201811431 A GB 201811431A GB 201811431 D0 GB201811431 D0 GB 201811431D0
Authority
GB
United Kingdom
Prior art keywords
cancer treatment
cancer
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1811431.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Open University
Original Assignee
Open University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Open University filed Critical Open University
Priority to GBGB1811431.4A priority Critical patent/GB201811431D0/en
Publication of GB201811431D0 publication Critical patent/GB201811431D0/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N2005/1092—Details
    • A61N2005/1098—Enhancing the effect of the particle by an injected agent or implanted device
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/15—Nucleic acids forming more than 2 strands, e.g. TFOs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/35—Nature of the modification
    • C12N2310/351—Conjugate
GBGB1811431.4A 2018-07-12 2018-07-12 Cancer treatment Ceased GB201811431D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB1811431.4A GB201811431D0 (en) 2018-07-12 2018-07-12 Cancer treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1811431.4A GB201811431D0 (en) 2018-07-12 2018-07-12 Cancer treatment

Publications (1)

Publication Number Publication Date
GB201811431D0 true GB201811431D0 (en) 2018-08-29

Family

ID=63273283

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1811431.4A Ceased GB201811431D0 (en) 2018-07-12 2018-07-12 Cancer treatment

Country Status (1)

Country Link
GB (1) GB201811431D0 (en)

Similar Documents

Publication Publication Date Title
IL271946A (en) Combination cancer therapy
IL263802A (en) Cancer treatment combinations
ZA202005847B (en) Cancer therapy
PT3576740T (en) Cancer treatment
GB201903546D0 (en) Cancer treatment
GB201813876D0 (en) Treatment
GB201820660D0 (en) Cancer treatments
SG11202011117VA (en) Treatment of cancer
GB201706451D0 (en) Cancer treatment
IL287652A (en) Cancer treatment
IL282093A (en) Combination therapy for cancer
SG11202010528XA (en) Combinations for treating cancer
GB201800546D0 (en) Treatment
IL285466A (en) Cancer treatment
HK1251794A1 (en) Cancer treatment
GB201800733D0 (en) Cancer
IL274626A (en) Cancer treatment
IL268463A (en) Cancer treatment
GB201814487D0 (en) Cancer
EP3576791A4 (en) Calreticulin-mediated cancer treatment
IL288035A (en) Cancer treatment
GB201707864D0 (en) Platinum-reistant cancer treatment
GB201704909D0 (en) Cancer therapy
GB201819920D0 (en) Cancer treatment
GB201711855D0 (en) Cancer therapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)